Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin

被引:709
|
作者
Kenny-Walsh, E [1 ]
机构
[1] Cork Univ Hosp, Dept Med, Cork, Ireland
来源
NEW ENGLAND JOURNAL OF MEDICINE | 1999年 / 340卷 / 16期
关键词
D O I
10.1056/NEJM199904223401602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Methods In February 1994, batches of anti-D immune globulin used in Ireland during 1977 and 1978 to prevent Rh isoimmunization were found to be contaminated with hepatitis C virus (HCV) from a single infected donor. In March 1994, a national screening program was initiated for all women who had received anti-D immune globulin between 1970 and 1994. Of the 62,667 women who had been screened when this study began, 704 (1.1 percent) had evidence of past or current HCV infection, and 390 of those 704 (55 percent) had positive tests for serum HCV RNA on reverse-transcription-polymerase-chain-reaction analysis. All 390 Were offered a referral for clinical assessment and therapy. We evaluated 376 of these 390 women (96 percent); the other 14 were not seen at one of the designated treatment centers. Results The mean (+/-SD) age of the 376 women was 45+/-6 years at the time of screening. They had been infected with hepatitis C for about 17 years. A total of 304 women (81 percent) reported symptoms, most commonly fatigue (248 women [66 percent]). Serum alanine aminotransferase concentrations were slightly elevated (40 to 99 U per liter) in 176 of 371 women (47 percent), and the concentrations were 100 U per liter or higher in 31 (8 percent). Liver biopsies showed inflammation in 356 of 363 women (98 percent); in most cases the inflammation was slight (41 percent) or moderate (52 percent). Although the biopsy samples from 186 of the 363 women (51 percent) showed evidence of fibrosis, only 7 women (2 percent) had probable or definite cirrhosis. Two of the seven reported excessive alcohol consumption. Conclusions Most of the women with HCV infection 17 years after receiving HCV-contaminated anti-D immune globulin had evidence of slight or moderate hepatic inflammation on liver biopsy, about half had fibrosis, and 2 percent had probable or definite cirrhosis, (N Engl J Med 1999;340:1228-33.) (C) 1999, Massachusetts Medical Society.
引用
收藏
页码:1228 / 1233
页数:6
相关论文
共 50 条
  • [21] Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation
    Lawlor, E
    Power, J
    Garson, JA
    Yap, PL
    Davidson, F
    Columb, G
    Smith, D
    Pomeroy, L
    O'Riordan, J
    Simmonds, P
    Tedder, RS
    VOX SANGUINIS, 1999, 76 (03) : 138 - 143
  • [22] Clinical course of hepatitis C in 23 women 20 years after infection through contaminated anti-D-prophylaxis
    Ernst, F
    Schwerdtfeger, M
    Martin, P
    Lotterer, E
    Fleig, WE
    GUT, 1997, 41 : A133 - A133
  • [23] ELEVATED ANTI-D TITER AFTER THE ADMINISTRATION OF RH-IMMUNE GLOBULIN - A CASE-REPORT
    ANDRES, RL
    BRANCH, DW
    SCOTT, JR
    JOURNAL OF REPRODUCTIVE MEDICINE, 1989, 34 (04) : 318 - 320
  • [24] Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura
    Rubinstein, Paul G.
    Chen, Yi-Hsiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (08) : 684 - 685
  • [25] Comparison of Intravenous Immune Globulin and High Dose Anti-D Immune Globulin as Initial Therapy for Childhood Immune Thrombocytopenic Purpura
    Kane, Ian
    Ragucci, Dominic
    Shatat, Ibrahim
    Kalpatthi, Ram
    BLOOD, 2008, 112 (11) : 1177 - 1178
  • [26] THERAPEUTIC TREATMENT WITH ANTI-D IMMUNE GLOBULIN FOR ITP: PREDICTING INDIVIDUAL RESPONSES
    Despotovic, Jenny
    McGann, Patrick
    Smeltzer, Matthew
    Aygun, Banu
    Ware, Russell
    PEDIATRIC BLOOD & CANCER, 2012, 58 (07) : 1030 - 1030
  • [27] Lack of anti-D in women at birth following antepartum immune globulin prophylaxis
    Rudensky, B
    Mazaki, E
    Na'amad, M
    Samueloff, A
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2003, 107 (01): : 45 - 46
  • [28] Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura
    Kane, Ian
    Ragucci, Dominic
    Shatat, Ibrahim F.
    Bussel, James
    Kalpatthi, Ram
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (01) : 79 - 83
  • [29] INSIGHT INTO HEPATITIS C VIRUS INFECTION; A COHORT STUDY OF WOMEN INFECTED WITH CONTAMINATED ANTI-D IMMUNOGLOBULIN IN IRELAND BETWEEN 1977 AND 1979
    Garvey, P.
    Thornton, L.
    Murphy, N.
    Flanagan, P.
    Norris, S.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S623 - S623
  • [30] Disease outcomes in a cohort of women in Ireland infected by hepatitis C-contaminated anti-D immunoglobulin during 1970s
    Garvey, Patricia
    Murphy, Niamh
    Flanagan, Paula
    Brennan, Aline
    Courtney, Garry
    Crosbie, Orla
    Crowe, John
    Hegarty, John
    Lee, John
    McIver, Margaret
    McNulty, Carol
    Murray, Frank
    Nolan, Niamh
    O'Farrelly, Cliona
    Stewart, Stephen
    Tait, Michele
    Norris, Suzanne
    Thornton, Lelia
    JOURNAL OF HEPATOLOGY, 2017, 67 (06) : 1140 - 1147